Key Points
- Campbell Rogers sold 65,153 shares of HeartFlow on Feb. 12 at an average price of $24.49 for a total of about $1.5956M, reducing his stake by 46.15% to 76,034 shares (≈$1.862M).
- Analyst sentiment is broadly positive with five Buys, two Holds and one Sell, and a consensus price target of $38.50 after several firms raised their targets in recent months.
- Institutional activity picked up in Q4: Freestone Grove boosted its stake 400% to 150,000 shares, and Capricorn Investment Group opened a large new position worth ≈$48.18M, while other funds also added shares.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) insider Campbell Rogers sold 65,153 shares of the company's stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $24.49, for a total transaction of $1,595,596.97. Following the completion of the sale, the insider directly owned 76,034 shares in the company, valued at approximately $1,862,072.66. This represents a 46.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Heartflow Price Performance
Shares of NASDAQ HTFL opened at $22.27 on Wednesday. The company has a market capitalization of $1.90 billion and a P/E ratio of -12.30. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $41.22. The business's fifty day moving average price is $29.74.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Freestone Grove Partners LP raised its holdings in shares of Heartflow by 400.0% in the 4th quarter. Freestone Grove Partners LP now owns 150,000 shares of the company's stock worth $4,372,000 after acquiring an additional 120,000 shares during the last quarter. Sandia Investment Management LP increased its holdings in Heartflow by 112.2% during the 4th quarter. Sandia Investment Management LP now owns 15,917 shares of the company's stock worth $464,000 after purchasing an additional 8,417 shares in the last quarter. Rock Springs Capital Management LP raised its stake in shares of Heartflow by 11.1% in the fourth quarter. Rock Springs Capital Management LP now owns 277,700 shares of the company's stock worth $8,095,000 after purchasing an additional 27,700 shares during the last quarter. Capricorn Investment Group LLC bought a new position in shares of Heartflow in the fourth quarter valued at approximately $48,178,000. Finally, California State Teachers Retirement System purchased a new position in shares of Heartflow during the fourth quarter valued at approximately $603,000.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on the company. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Heartflow in a research note on Monday, December 29th. JPMorgan Chase & Co. raised their price objective on shares of Heartflow from $36.00 to $40.00 and gave the stock an "overweight" rating in a research report on Thursday, November 13th. Stifel Nicolaus boosted their target price on shares of Heartflow from $35.00 to $40.00 and gave the company a "buy" rating in a research report on Thursday, November 13th. Wells Fargo & Company initiated coverage on shares of Heartflow in a report on Wednesday, January 28th. They issued an "overweight" rating and a $38.00 price target for the company. Finally, Canaccord Genuity Group lifted their price target on shares of Heartflow from $39.00 to $40.00 and gave the company a "buy" rating in a research note on Thursday, November 13th. Five research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $38.50.
Get Our Latest Analysis on HTFL
About Heartflow
(
Get Free Report)
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
